Irritable bowel syndrome (IBS) is a prevalent and debilitating gastrointestinal disorder affecting approximately 5%–10% of ...

Irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) affect the digestive tract and cause symptoms ...

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.